Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03539432 · ClinicalTrials.gov registry record · Phase 2
Exploration of Gemfibrozil as a Treatment for AUD
A Phase 2 study, sponsored by The Mind Research Network.
- Terminated
- Registry status
- Phase 2
- Development phase
- 3
- Enrollment target
NCT03539432 is a Phase 2 study that was terminated before completion, run by The Mind Research Network. The registered enrollment target is 3 participants.
The verdict
NCT03539432, a Phase 2 study, was terminated before completion, sponsored by The Mind Research Network.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 3 participants
- Enrollment target
Study Summary
This study will examine the efficacy of the medication gemfibrozil in reducing alcohol consumption in individuals with an alcohol use disorder who are seeking treatment for alcohol-related problems. Twenty individuals will be randomized to receive four weeks of either gemfibrozil or placebo and retrospective reports of alcohol use will be collected throughout the trial. In addition, brain imaging measures will be collected at baseline and after two weeks of treatment to determine the effects of gemfibrozil on brain functioning.
Interventions
- DRUG Placebo oral capsule
- DRUG Gemfibrozil 600 MG
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2018-05-16 |
| Est. Completion | 2018-12-30 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03539432
The ClinicalTrials.gov registry entry for NCT03539432 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Mind Research Network, which has 17 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo oral capsule is the first listed.
NCT03539432 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03539432 about?
NCT03539432 is a clinical study titled "Exploration of Gemfibrozil as a Treatment for AUD". This study will examine the efficacy of the medication gemfibrozil in reducing alcohol consumption in individuals with an alcohol use disorder who are seeking treatment for alcohol-related problems. Twenty individuals will be randomized to receive four weeks of either gemfibrozil or placebo and retr...
What is the current status of trial NCT03539432?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 3 participants. The study started on 2018-05-16. Estimated completion is 2018-12-30.
What interventions are being tested in trial NCT03539432?
The interventions under investigation include: Placebo oral capsule (DRUG), Gemfibrozil 600 MG (DRUG).
Who is sponsoring clinical trial NCT03539432?
This trial is sponsored by The Mind Research Network, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.